Should ALCL Stage III Patients Consider Autologous Transplant?

Is autologous stem cell transplantation necessary for stage III anaplastic large cell lymphoma (ALCL)?

A patient with stage III Anaplastic Large Cell Lymphoma (ALCL) has undergone their fifth cycle of CHOP chemotherapy.
The treatment plan mentioned by the physician includes autologous stem cell transplantation.
However, prior to the fifth chemotherapy cycle, a PET scan was performed, and currently, no cancer cells are detectable in the body.
Is it true that if the PET scan does not show cancer in the blood, it means there are none? Why does the patient still feel unusual? The doctor believes that there are cases where patients choose not to undergo transplantation and still have good outcomes.
Of course, undergoing transplantation does not guarantee that there will be no relapse.
The doctor mentioned that if the patient opts out of transplantation, they would need to undergo two additional cycles of chemotherapy (making it a total of seven).
If transplantation is chosen, preparations for it would need to begin after the next treatment.
Is transplantation the better option, or is it preferable not to undergo it? The patient finds it psychologically challenging to make this decision.
Could the doctor provide valuable advice for consideration? Additionally, what is the recovery period after transplantation, and when can the patient return to work like a normal person? Thank you in advance for the valuable insights from the doctor.
I am very grateful.

Xiao Yu, 30~39 year old female. Ask Date: 2008/12/09

Dr. Fan Sheng reply Oncology

Currently, there is a lack of large-scale clinical studies providing us with strong evidence for a universally satisfactory answer to this question.
To be frank, in the case of anaplastic large cell lymphoma (ALCL), if the anaplastic lymphoma kinase (ALK) is positive, the prognosis is quite good with chemotherapy alone.
If ALK is negative, autologous stem cell transplantation can be included in the first-line treatment plan from the outset.
Another approach is to wait until relapse before proceeding with allogeneic transplantation.
I would adopt this strategy, but each physician has their own philosophy, and it cannot be said that one is definitively correct.

Reply Date: 2008/12/09

More Info

When considering whether an autologous stem cell transplant (ASCT) is appropriate for a patient with Stage III anaplastic large cell lymphoma (ALCL) who has undergone multiple cycles of CHOP chemotherapy, several factors must be taken into account.
Firstly, it is important to understand the nature of ALCL and the implications of the patient's current treatment response. ALCL is a type of non-Hodgkin lymphoma that can be aggressive, and the treatment typically involves chemotherapy followed by consolidation therapy, which may include ASCT. The fact that the patient has undergone five cycles of CHOP chemotherapy and has had a PET scan showing no detectable cancer cells is a positive sign. However, it is crucial to note that a negative PET scan does not guarantee the complete absence of disease. There may still be residual microscopic disease that is not detectable by imaging, which could lead to relapse.

The decision to proceed with ASCT should be based on a thorough evaluation of the patient's overall health, the response to previous treatments, and the potential benefits and risks associated with the transplant. ASCT can provide a chance for a cure, especially in patients who have achieved a complete response to chemotherapy. However, it is not without risks, including complications such as infections, organ damage, and the possibility of relapse.
In this case, the physician's suggestion that some patients choose not to undergo ASCT and still achieve good outcomes is valid. The decision should be personalized, taking into account the patient's preferences, the likelihood of relapse without the transplant, and the potential for improved outcomes with ASCT. It is also important to consider the patient's psychological readiness for the procedure, as the process can be physically and emotionally taxing.

Regarding the recovery period after ASCT, it typically varies from patient to patient. Generally, the initial recovery phase in the hospital may last from a few weeks to a month, depending on the patient's response to the transplant and any complications that may arise. After discharge, patients often require several months to fully recover their strength and immune function. During this time, they may need to avoid crowded places and take precautions to prevent infections. Many patients can gradually return to work and normal activities within 3 to 6 months post-transplant, but this timeline can vary significantly based on individual circumstances.

In summary, the decision to proceed with an autologous stem cell transplant for a patient with Stage III ALCL should be made collaboratively between the patient and their healthcare team, considering the patient's treatment response, overall health, and personal preferences. It is essential to have open discussions about the potential benefits and risks of the transplant, as well as the expected recovery timeline. Ultimately, the goal is to achieve the best possible outcome for the patient while ensuring they are comfortable with their treatment choices.

Similar Q&A

Is Autologous Stem Cell Transplant Necessary After Venclexta for Myeloma?

Hello Doctor: My mother is 55 years old and has been diagnosed with multiple myeloma. After three cycles of treatment with Velcade, her hemoglobin has improved to 9.5 and her immunoglobulin levels have decreased to 4200. Given these results, is it still necessary for her to under...

Dr. Fan Sheng reply Oncology
Mr. Hsieh: If the immunoglobulin level you mentioned dropping to 4200 refers to the abnormal immunoglobulin, then this level may not be sufficient for autologous stem cell transplantation. It is necessary to wait until the abnormal cells in the bone marrow are reduced to a certai...

Is Local Radiation Necessary After Total Mastectomy for Stage IIB Triple-Negative Breast Cancer?

My mother, who is 77 years old, underwent a right total mastectomy and axillary lymph node dissection on January 20. The postoperative pathology report indicated triple-negative breast cancer, stage IIB T3N0M0, with a tumor size of 10 cm and a histological grade of III. There was...

Dr. Lai Yicheng reply Oncology
Dear Ms. Jojo, Thank you for your letter. I would like to respond as follows: Your mother has been diagnosed with right-sided breast cancer, T3N0M0, with a tumor size of 10 cm, grade 3, triple-negative, and stage IIB. 1. Adjuvant chemotherapy and radiotherapy are the standard ...

Understanding Post-Transplant Challenges in Lymphoma Patients

Hello, my father was diagnosed with lymphoma last year and has undergone several rounds of chemotherapy, but each time it was halted due to low white blood cell counts. Recently, he underwent an autologous stem cell transplant, and his white blood cell count has been around 50. I...

Dr. Fan Sheng reply Oncology
It's really difficult to answer. Based on what you've described, the situation is very critical, and we can only ask your father's physician to do everything possible to save him.

Understanding Aplastic Anemia: Treatment Options and Travel Considerations

Hi! About 2 weeks ago, I wrote an email to see if you could refer me to any hospital for leukemia. Thanks for your attention. My friend finally got the English name for her sister’s disease—“Aplastic Anemia.” She is actually in Thailand and is Thai. For this kind of disease, can ...

Dr. Fan Sheng reply Oncology
Dear Vivien, Aplastic anemia is referred to as "再生不良性貧血" in Mandarin. It is not a malignant disease, but severe forms of aplastic anemia can be life-threatening. The best treatment is hematopoietic stem cell transplantation, using either bone marrow or peripheral blood...